TAB Olaparib 150mg, available at Maharashtra Medical in Pune, represents a significant advancement in the treatment of advanced cancers with specific genetic mutations, such as BRCA mutations. This medication falls under the category of PARP (poly ADP-ribose polymerase) inhibitors, which are targeted therapies designed to exploit a vulnerability in cancer cells' DNA repair processes.
Olaparib works by inhibiting PARP enzymes, which are involved in repairing damaged DNA in cells. Cancer cells with mutations in genes like BRCA1 or BRCA2 are particularly susceptible to PARP inhibition because they rely heavily on PARP for DNA repair. By blocking PARP, Olaparib prevents cancer cells from repairing their DNA effectively, leading to their demise through a process known as synthetic lethality.
This medication is primarily indicated for the treatment of advanced ovarian cancer, breast cancer, and metastatic castration-resistant prostate cancer in patients with specific genetic mutations. It is often used when other treatments have failed or in cases where traditional chemotherapy may not be as effective.
At Maharashtra Medical, we prioritize the quality and efficacy of our medications, ensuring that Olaparib 150mg tablets are sourced from reputable manufacturers and stored under optimal conditions. Our healthcare professionals provide comprehensive support to patients, including guidance on proper usage, potential side effects, and the importance of regular monitoring. We aim to empower patients with the knowledge and resources they need to navigate their treatment journey effectively and improve their overall quality of life.
Go to homepage
